Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study
暂无分享,去创建一个
I. Bruce | D. Gladman | C. Gordon | D. Isenberg | K. Kalunian | O. Nived | M. Petri | J. Sánchez-Guerrero | M. Urowitz | G. Alarcón | S. Bae | V. Farewell | K. Steinsson | M. Khamashta | E. Svenungsson | D. Wallace | G. Ruiz-Irastorza | D. Kamen | M. Inanç | J. Merrill | S. Manzi | R. Ramsey‐Goldman | M. Ramos-Casals | A. Clarke | P. Fortin | C. Peschken | J. Hanly | Anisur Rahman | R. Vollenhoven | S. Jacobsen | C. Aranow | M. Mackay | J. Romero-Diaz | E. Ginzler | M. Dooley | S. Lim | A. Askanase | Qiuju Li | S. Bernatsky | A. Zoma | C. Theriault | L. Su | A. Jonsen | J. Romero-Díaz | G. Ruiz‐Irastorza | A. Clarke | S. Bae | Li Su | Ronald F. Vollenhoven
[1] D. Nikolopoulos,et al. Cerebrovascular Events in Systemic Lupus Erythematosus: Diagnosis and Management , 2019, Mediterranean journal of rheumatology.
[2] M. Govoni,et al. Peripheral nervous system involvement in systemic lupus erythematosus: a retrospective study on prevalence, associated factors and outcome , 2019, Lupus.
[3] Sindhu R. Johnson,et al. Multicenter Delphi Exercise to Identify Important Key Items for Classifying Systemic Lupus Erythematosus , 2018, Arthritis care & research.
[4] I. Bruce,et al. Cerebrovascular Events in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study , 2018, Arthritis care & research.
[5] E. Morand,et al. Discordance of patient and physician health status concerns in systemic lupus erythematosus , 2018, Lupus.
[6] J. Valls-Solé,et al. Peripheral nervous system involvement in systemic lupus erythematosus: Prevalence, clinical and immunological characteristics, treatment and outcome of a large cohort from a single centre. , 2017, Autoimmunity reviews.
[7] Caroline Gordon,et al. The frequency and outcome of lupus nephritis: results from an international inception cohort study. , 2016, Rheumatology.
[8] H. Helmy,et al. Detection of asymptomatic cranial neuropathies in patients with systemic lupus erythematosus and their relation to antiribosomal P antibody levels and disease activity , 2014, Clinical Rheumatology.
[9] Cheng-Hsien Lu,et al. The Association between Autoantibodies and Peripheral Neuropathy in Lupus Nephritis , 2014, BioMed research international.
[10] M. Petri,et al. Peripheral Neuropathies in Systemic Lupus Erythematosus: Clinical Features, Disease Associations, and Immunologic Characteristics Evaluated Over a Twenty‐Five–Year Study Period , 2014, Arthritis & rheumatology.
[11] I. Bruce,et al. Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study , 2012, Annals of the rheumatic diseases.
[12] M. Labrador-Horrillo,et al. Anti-ganglioside antibodies in patients with systemic lupus erythematosus and neurological manifestations , 2012, Lupus.
[13] Gerald McGwin,et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. , 2012, Arthritis and rheumatism.
[14] D. Gladman,et al. Peripheral neuropathy in patients with systemic lupus erythematosus. , 2011, Seminars in arthritis and rheumatism.
[15] I. Bruce,et al. SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus , 2011, Annals of the rheumatic diseases.
[16] I. Bruce,et al. Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study. , 2008, Arthritis and rheumatism.
[17] I. Bruce,et al. Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. , 2008, Arthritis and rheumatism.
[18] P. Emery,et al. The validity of the inclusion of "lupus headache" in the Systemic Lupus Erythematosus Disease Activity Index. , 2007, Arthritis and rheumatism.
[19] I. Bruce,et al. Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. , 2007, Arthritis and rheumatism.
[20] D. Isenberg,et al. Systemic Lupus International Collaborating Group—onwards and upwards? , 2006, Lupus.
[21] R. Omdal,et al. Small-diameter nerve fiber neuropathy in systemic lupus erythematosus. , 2006, Archives of neurology.
[22] M. Weisman,et al. Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome. , 2005, Seminars in arthritis and rheumatism.
[23] J. Merrill,et al. Dual antibody reactivity to β2-glycoprotein I and protein S: increased association with thrombotic events in the antiphospholipid syndrome , 2002, Lupus.
[24] D. Gladman,et al. Systemic lupus erythematosus disease activity index 2000. , 2002, The Journal of rheumatology.
[25] A. Auvinen,et al. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. , 2001, Arthritis and rheumatism.
[26] J. Suarez,et al. Acute motor-sensory axonal neuropathy associated with active systemic lupus erythematosus and anticardiolipin antibodies. , 2001, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[27] J. Merrill,et al. Enhancement of protein S anticoagulant function by beta2-glycoprotein I, a major target antigen of antiphospholipid antibodies: beta2-glycoprotein I interferes with binding of protein S to its plasma inhibitor, C4b-binding protein. , 1999, Thrombosis and haemostasis.
[28] Caroline Gordon,et al. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. , 1999, Arthritis and rheumatism.
[29] S. Ho,et al. Peripheral neuropathy in systemic lupus erythematosus. , 1999, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.
[30] T. Ng,et al. Validation of the MOS SF-36 for quality of life assessment of patients with systemic lupus erythematosus in Singapore. , 1999, The Journal of rheumatology.
[31] M. Hochberg,et al. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.
[32] J. Merrill,et al. High prevalence of antiphospholipid antibodies in patients taking procainamide. , 1997, The Journal of rheumatology.
[33] D. Symmons,et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. , 1996, Arthritis and rheumatism.
[34] J. Schölmerich,et al. Autonomic and sensorimotor neuropathy in patients with systemic lupus erythematosus and systemic sclerosis. , 1996, The Journal of rheumatology.